Mangoceuticals, Inc. Common Stock Financial Flexibility Index
Mangoceuticals, Inc. Common Stock financial flexibility index. Mangoceuticals, Inc. Common Stock (MGRX) has a Financial Flexibility Index of -0.16x as of June 2026. Free cash flow of $-260.51K (operating CF $-260.51K minus capex $0.00) represents 0% of total liabilities ($1.65 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Mangoceuticals, Inc. Common Stock (2021–2025)
Financial flexibility index of Mangoceuticals, Inc. Common Stock from 2021 to 2025. Historical Financial Flexibility Index trend for Mangoceuticals, Inc. Common Stock across 5 annual periods. Explore MGRX operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Mangoceuticals, Inc. Common Stock Financial Flexibility Index by Year (2021–2025)
Mangoceuticals, Inc. Common Stock financial flexibility index by year from 2021 to 2025. Year-by-year free cash flow to debt coverage for Mangoceuticals, Inc. Common Stock. For the full cash flow conversion analysis, see Mangoceuticals, Inc. Common Stock (MGRX) cash conversion ratio.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -6.57x | $-5.85 Million | $-5.85 Million | $890.57K | ▼ -92.5% |
| 2024 | -3.41x | $-4.86 Million | $-4.86 Million | $1.43 Million | ▲ +86.5% |
| 2023 | -25.34x | $-6.99 Million | $-7.00 Million | $276.04K | ▼ -656.7% |
| 2022 | -3.35x | $-1.30 Million | $-1.35 Million | $389.26K | ▼ -614.0% |
| 2021 | 0.65x | $25.58K | $-17.52K | $39.27K | — |